BioCentury
ARTICLE | Company News

Urigen genitourinary news

May 4, 2009 7:00 AM UTC

Urigen is seeking strategic alternatives, including the license or formation of a JV around its URG101 and URG301. URG101 is an intravesical formulation of heparin and alkalinized lidocaine for pain...